Two instances of governments in less developed parts of the world trying to enforce their rights under TRIPS (Trade Related Aspects of Intellectual Property) are detailed in the Lancet. One involves India, and their decision not to grant a patent to a cancer drug (the patent was rejected under the terms of TRIPS), and the other involves Thailand and the Thai government's authorisation of local manufacture of an anti-HIV drug (a right that the government has under TRIPS).
Read more in the Lancet (link via DOI).
No comments:
Post a Comment